AN OPEN-LABEL, SINGLE-TREATMENT, SINGLE-PERIOD, SINGLE DOSE, CLINICAL PHASE 1 STUDY TO ASSESS THE SAFETY AND TOLERABILITY OF LIVE MEASLES VACCINE, (MULTIPLE DOSE VIAL FORMULATION) OF M/s CADILA HEALTHCARE LTD., INDIA IN HEALTHY, ADULT, MALE, HUMAN SUBJECTS UNDER FASTING CONDITION
Latest Information Update: 30 Aug 2016
At a glance
- Drugs Measles virus vaccine live (Primary)
- Indications Measles
- Focus Adverse reactions
- Sponsors Cadila Healthcare
- 01 Oct 2012 New trial record